Evidence for the onset of COPD in childhood, and the role of genetics Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence Year: 2005
Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1 ) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008
FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007
Does rapid decline predict poor prognosis? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007
Forced inspiratory volume in one second (FIV1 ) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002
Why is there often discordance between cross sectional and longitudinal studies of dust-induced COPD? Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005
How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1 Source: Eur Respir J 2009; 33: 1396-1402 Year: 2009
Lung function decline, chronic bronchitis and occupational exposures during the follow-up of the ECRHS Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005
The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Early life origins of adult lung function Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function Year: 2006
Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=281 Year: 2006
Forced expiratory volume in one second (FEV1 ) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Inspiratory capacity-to-total lung capacity ratio is related to expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Lung function I Year: 2007
Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005